Literature DB >> 7530653

Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostatic cancer cells, LNCaP, by dihydrotestosterone.

C Lee1, D M Sutkowski, J A Sensibar, D Zelner, I Kim, I Amsel, N Shaw, G S Prins, J M Kozlowski.   

Abstract

LNCaP is an androgen-sensitive human prostatic cancer cell line. The effect of androgen on these cells is characterized by a bell-shaped growth response and a dose-dependent induction of prostate-specific antigen (PSA) production. The present study was carried out to gain further insight into the effect of androgen on LNCaP. Cells were cultured in phenol red-free RPMI-1640 supplemented with 10% charcoal-stripped fetal bovine serum, with concentrations of dihydrotestosterone (DHT) ranging from 0-10(-7) M, in a 4-day culture system. A bell-shaped growth response was reproduced with a peak level of cell count at 10(-10) M DHT. PSA secretion from these cells did not increase significantly until the DHT level in the medium reached 10(-9) M. A progressive increase in PSA secretion was observed at higher DHT concentrations accompanied with a progressive decline in cellular proliferation. The results of immunocytochemical analysis of PSA localization indicated that the proportion of cells with positive staining for PSA also increased with increasing concentrations of DHT. Analysis of androgen receptors, as determined by both immunocytochemistry and Western blot analysis, showed a decline in nuclear androgen receptor at low concentrations of DHT and an increase in the amount of receptor protein at high concentrations. These results indicated that the androgen-induced bell-shaped growth response in LNCaP cells represented the manifestation of two different cellular events in dose-related manner: cellular proliferation at low DHT concentrations and increased production of PSA at high DHT concentrations.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7530653     DOI: 10.1210/endo.136.2.7530653

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  29 in total

1.  Effects of extracellular nucleotides and nucleosides on prostate carcinoma cells.

Authors:  R Janssens; J M Boeynaems
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

2.  Inhibition of aberrant androgen receptor induction of prostate specific antigen gene expression, cell proliferation and tumor growth by 17α-estradiol in prostate cancer.

Authors:  Yaming Qiao; Lu Wang; Li-Qun Cai; Chen Tan; Julianne Imperato-McGinley; Yuan-Shan Zhu
Journal:  J Urol       Date:  2011-01       Impact factor: 7.450

3.  Configurations of a two-tiered amplified gene expression system in adenoviral vectors designed to improve the specificity of in vivo prostate cancer imaging.

Authors:  M Sato; M L Figueiredo; J B Burton; M Johnson; M Chen; R Powell; S S Gambhir; M Carey; L Wu
Journal:  Gene Ther       Date:  2008-02-28       Impact factor: 5.250

4.  DHX15 is up-regulated in castration-resistant prostate cancer and required for androgen receptor sensitivity to low DHT concentrations.

Authors:  Yadong Xu; Qiong Song; Laura E Pascal; Mingming Zhong; Yibin Zhou; Jianhua Zhou; Fang-Ming Deng; Jiaoti Huang; Zhou Wang
Journal:  Prostate       Date:  2019-02-03       Impact factor: 4.104

5.  Androgen receptor expression in primary prostate cancers of Lobund-Wistar rats and in tumor-derived cell lines.

Authors:  J M Bentel; M A Pickering; M Pollard; J A Clements; W D Tilley
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999 Nov-Dec       Impact factor: 2.416

6.  The regulation of prostate cancer cell adhesion to human bone marrow endothelial cell monolayers by androgen dihydrotestosterone and cytokines.

Authors:  Carlton R Cooper; Jasmine K Bhatia; Heather J Muenchen; Lisa McLean; Satoru Hayasaka; Jeremy Taylor; Paul J Poncza; Kenneth J Pienta
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

7.  Caspase-2-Based Regulation of the Androgen Receptor and Cell Cycle in the Prostate Cancer Cell Line LNCaP.

Authors:  Agshin F Taghiyev; Oskar W Rokhlin; Rebecca B Glover
Journal:  Genes Cancer       Date:  2011-07

8.  Knockdown of STEAP1 inhibits cell growth and induces apoptosis in LNCaP prostate cancer cells counteracting the effect of androgens.

Authors:  Inês Margarida Gomes; Sandra Moreira Rocha; Carlos Gaspar; Maria Inês Alvelos; Cecília Reis Santos; Sílvia Socorro; Cláudio Jorge Maia
Journal:  Med Oncol       Date:  2018-02-20       Impact factor: 3.064

9.  Proteomic analysis of patient tissue reveals PSA protein in the stroma of benign prostatic hyperplasia.

Authors:  Katherine J O'Malley; Kurtis Eisermann; Laura E Pascal; Anil V Parwani; Tsuyoshi Majima; Lara Graham; Katherine Hrebinko; Marie Acquafondata; Nicolas A Stewart; Joel B Nelson; Naoki Yoshimura; Zhou Wang
Journal:  Prostate       Date:  2014-04-07       Impact factor: 4.104

10.  HDAC6 regulates androgen receptor hypersensitivity and nuclear localization via modulating Hsp90 acetylation in castration-resistant prostate cancer.

Authors:  Junkui Ai; Yujuan Wang; Javid A Dar; June Liu; Lingqi Liu; Joel B Nelson; Zhou Wang
Journal:  Mol Endocrinol       Date:  2009-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.